Enchi Liu
Seminars
Wednesday 3rd June 2026
Panel Discussion: Given Recent Failures, How Can We Tailor ALS Clinical Trials to Successfully Meet Regulatory Expectations
2:10 pm
- Outlining the approval path for sporadic and familial ALS: is it the same for different modalities? What is the regulatory bar for approving this?
- Harnessing innovative trial design
- Cross comparing diverging requirements for different regulatory agencies including the FDA, EMA and more
- Establishing clear, patient-relevant endpoints and leveraging biomarkers to demonstrate efficacy
- Critically identifying stumbling blocks in IND and BLA packages to circumvent late-stage failures and pitfalls in drug development
Wednesday 3rd June 2026
Chair’s Opening Remarks
8:25 am
Thursday 4th June 2026
Chair’s Opening Remarks
9:25 am
Wednesday 3rd June 2026
Chair’s Closing Remarks
5:50 pm
Thursday 4th June 2026
Chair’s Closing Remarks
3:30 pm
